Examkin

Soru

Zorluk: ZorGynecologic Oncology

A 68-year-old woman is brought to the clinic for evaluation of blood-tinged vaginal discharge that started 3 weeks ago. She attained menopause at age 52. Her medical history is significant for hypertension, obesity, and estrogen receptor-positive breast cancer diagnosed 3 years ago, for which she was treated with a lumpectomy and radiation therapy. She is currently taking tamoxifen. Pelvic examination reveals a small amount of dark blood in the vaginal vault. The cervix appears flush with the vagina and is severely stenotic. A transvaginal ultrasound shows an endometrial thickness of 14 mm with multiple small cystic spaces. An attempt to perform an in-office endometrial biopsy is unsuccessful because the sampling device cannot pass through the external cervical os, despite the use of a tenaculum and misoprostol preparation. Which of the following is the most appropriate next step in management?

  1. A
    Reassurance and repeat transvaginal ultrasound in 6 months
  2. B
    Discontinuation of tamoxifen and initiation of anastrozole
  3. C
    Pelvic magnetic resonance imaging
  4. Hysteroscopy with dilation and curettageCevap
  5. E
    Total extrafascial hysterectomy and bilateral salpingo-oophorectomy

Cevap

Hysteroscopy with dilation and curettage
This patient presents with postmenopausal bleeding and a significantly thickened endometrium while on tamoxifen, raising high clinical suspicion for endometrial hyperplasia or carcinoma. Although tamoxifen classically causes benign cystic changes in the endometrium, any vaginal bleeding in a postmenopausal woman requires a definitive tissue diagnosis. Because an in-office endometrial biopsy cannot be completed due to severe cervical stenosis, the next most appropriate step is hysteroscopy with dilation and curettage (D&C) under anesthesia. This approach allows for mechanical dilation of the stenotic os, direct visualization of the uterine cavity to rule out focal lesions like polyps, and comprehensive tissue sampling.

Adım Adım Çözüm

1
Identify the primary clinical problem and the patient's risk factors.
The patient has postmenopausal bleeding with significant risk factors for endometrial cancer, including advanced age, obesity, and tamoxifen use.
Recognizing these high-risk features highlights the urgency of ruling out malignancy.
2
Interpret the diagnostic imaging findings in the context of the patient's history.
Transvaginal ultrasound shows a thickened endometrium (14 mm). Although subendometrial cystic spaces are characteristic of tamoxifen-induced changes, they do not exclude cancer.
Ultrasound findings cannot replace tissue histology when abnormal bleeding is present.
3
Assess the outcome of the initial diagnostic procedure.
The indicated in-office endometrial biopsy failed due to severe cervical stenosis.
An adequate tissue sample has not yet been obtained, leaving the diagnostic workup incomplete.
4
Select the appropriate alternative diagnostic modality.
Hysteroscopy with dilation and curettage is selected to safely dilate the cervix under anesthesia, directly visualize the cavity, and obtain the necessary tissue.
It is the standard, definitive secondary approach for a failed office endometrial sampling.

Anahtar Kavram

In postmenopausal women with vaginal bleeding, a failed in-office endometrial sampling (often due to cervical stenosis) necessitates further evaluation via hysteroscopy with dilation and curettage to definitively rule out endometrial carcinoma.
Bu soruyu puanla

Konular

Gynecologic Oncology

Bu konudan daha fazla soru